Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-549
TNBC
Basal B
GSK1838705A
IGF1R
RTK
5910.098
uM
8.24970
12.33540
-0.8174 -0.8459 2.4613 0.2304
0.9978
3.2046
BT-549
TNBC
Basal B
GSK1838705A
IGF1R
RTK
5909.098
uM
6.56190
8.060
-0.8961 -0.8980 5.0000 0.3085
0.9980
2.6253
BT-549
TNBC
Basal B
GSK1838705A
IGF1R
RTK
5909.092
uM
5.07990
6.30740
-0.7169 -0.7170 4.1102 0.3216
0.9990
3.0314
BT-549
TNBC
Basal B
GSK461364
PLK1
PLK
10261.001
uM
0.06157
0.15170
-0.4222 -0.4109 0.6651 0.5699
0.9713
2.3472
BT-549
TNBC
Basal B
GSK923295
CENPE
Kinesin
10261.001
uM
0.05714
0.05080
0.2077 0.2224 4.9999 0.3810
0.9940
2.3472
BT-549
TNBC
Basal B
GW-5074
CRAF
MAPK
5909.088
uM
inf
inf
1.0500 1.0500 0.0000 -0.0255
-2.9579
2.9659
BT-549
TNBC
Basal B
Ibandronate
FDPS
12305.143
uM
53.37830
83.05540
-0.1213 -0.2169 0.8149 0.2814
0.9980
2.9115
BT-549
TNBC
Basal B
ICRF-193
TOP2
TOP
12305.157
uM
inf
0.22786
0.6315 0.5881 0.3501 0.1796
0.8666
2.9955
BT-549
TNBC
Basal B
IKK16
IKK
NFKB
5909.093
uM
3.93910
5.24310
-0.7387 -0.7395 3.1748 0.3229
0.9982
2.8805
BT-549
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
5910.091
uM
30.89130
37.75620
-0.7258 -0.7260 4.4692 0.3217
0.9982
3.3208
BT-549
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
5909.092
uM
36.52830
49.83120
-0.7507 -0.7525 2.9569 0.3310
0.9990
3.0314
BT-549
TNBC
Basal B
Ispinesib
KSP
Kinesin
5909.067
uM
0.48057
4.71140
-0.8153 -1.0000 0.4813 0.3869
0.8366
2.8695
BT-549
TNBC
Basal B
Ispinesib
KSP
Kinesin
5910.067
uM
0.38893
4.22180
-0.8117 -1.0000 0.4607 0.4056
0.8370
3.2630
BT-549
TNBC
Basal B
Ixabepilone
TUBB
TUBB
5910.095
uM
0.00666
0.02630
-0.8108 -0.5522 0.5415 0.8403
0.9352
3.2727
BT-549
TNBC
Basal B
Ixabepilone
TUBB
TUBB
5909.095
uM
0.02139
0.25211
-0.8830 -1.0000 0.4454 0.7826
0.9588
2.7716
BT-549
TNBC
Basal B
JNK-IN-5A
JNK
JNK
12305.168
uM
0.91330
1.02980
-0.1585 -0.1267 1.8821 0.4405
0.9868
2.5025
BT-549
TNBC
Basal B
L-779450
BRAF
MAPK
12305.166
uM
50.02890
43.34140
0.8426 0.2560 4.9997 0.0132
0.6646
2.9556
BT-549
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
5910.098
uM
inf
inf
0.9455 0.9455 0.0000 -0.0163
0.2428
3.2046
BT-549
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
5909.098
uM
inf
6.25710
0.8768 0.8207 0.8467 0.0108
0.6521
2.6253
BT-549
TNBC
Basal B
LBH589
HDAC
HDAC
12305.167
uM
0.19318
0.45314
-0.5767 -0.6104 0.9358 0.5337
0.9989
2.8814
BT-549
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12305.167
uM
1.61670
6.36660
-0.7128 -1.0000 0.8015 0.3323
0.9667
2.8814
BT-549
TNBC
Basal B
Mebendazole
12690.174
uM
0.52406
0.39147
0.2665 0.2879 2.9394 0.2959
0.9947
2.4378
BT-549
TNBC
Basal B
Methotrexate
DHFR
Metabolism
5909.085
uM
inf
inf
0.9298 0.9298 0.0000 -0.0072
0.3654
3.0853
BT-549
TNBC
Basal B
Methotrexate
DHFR
Metabolism
5910.084
uM
inf
inf
0.9374 0.9374 0.0000 -0.0121
0.4733
3.1096
BT-549
TNBC
Basal B
Methylglyoxal
13153.184
uM
173.18360
482.92460
-0.9268 -0.9819 1.0594 0.7769
0.9329
2.3850